Combining biocatalyzed electrolysis with anaerobic digestion

Biocatalyzed electrolysis is a microbial fuel cell based technology for the generation of hydrogen gas and other reduced products out of electron donors. Examples of electron donors are acetate and wastewater. An external power supply can support the process and therefore circumvent thermodynamical constraints that normally render the generation of compounds such as hydrogen unlikely. We have investigated the possibility of biocatalyzed electrolysis for the generation of methane. The cathodically produced hydrogen could be converted into methane at a ratio of 0.41 mole methane mole(-1) acetate, at temperatures of 22+/-2 degrees C. The anodic oxidation of acetate was not hampered by ammonium concentrations up to 5 g N L(-1). An overview is given of potential applications for biocatalyzed electrolysis.

A novel electrospun polysulfone fiber membrane: application to advanced treatment of secondary bio-treatment sewage

Electrospun nanofibers and fine fibers have been used to remove submicron particles in air filtration. In this paper, direct-and polyaluminium chloride (PAC) pre-coagulation filtration of secondary bio-treatment sewage was studied using electrospun polysulfone fiber membrane (EPSFM). According to the results obtained, for direct filtration, suspended solids (SS), chemical oxygen demand (COD(Cr)) and NH3-N decreased 86.7, 71.2, 91.7% respectively, in filtrate of secondary bio-treatment sewage, while for PAC pre-coagulation filtration, the removal rate of SS, COD(Cr) and NH3-N reached 91.3, 85.3, 93.3 % respectively. EPSFM had a high efficiency in removing NH3-N, COD(Cr) and SS, especially for micron and submicron particles. EPSFM can reduce the content of some toxic metals, such as Cu, Zn and Ti, through interception and adsorption mechanism and can also remove dissolved organic matter such as humics and proteins through interception mechanism. EPSFM can remove some of volatile organic chemicals (VOCs) by adsorption and filtration, the removal rate of VOCs was in the range of 59-100 %. The number of VOCs in secondary bio-treatment sewage and its filtrate from direct filtration were 27 and 18 respectively, the major VOCs were benzene-, cyclohexane-, adamantine- and hydrocarbon derivates.

Concomitant intracerebral infusion of tissue plasminogen activator and thrombin leads to brain injury

Low doses of thrombin are neuroprotective while high doses are neurotoxic and lead to brain injury. However, evidence suggests that low doses of thrombin cause brain injury when infused concomitantly with tissue plasminogen activator (tPA), which is used clinically to facilitate evacuation of intracerebral hematomas. In this study, we examined the effects of intracerebral infusion of tPA and thrombin, individually and in combination. Rats were infused in the right basal ganglia with 50 microL saline solutions containing thrombin, tPA, or thrombin + tPA. In the first experiment, rats were used for blood-brain barrier (BBB) permeability measurements at 24 h after infusion. In the second experiment, animals were euthanized 3 days after infusion, and brain sections were stained with Fluoro-Jade to measure neuronal cell death. Behavioral tests were carried out before and after surgery. Infusion of thrombin + tPA markedly increased Evans blue tissue content in ipsilateral brain samples (p < 0.05). Fluoro-Jade-stained sections from thrombin + tPA group demonstrated significantly higher cell death counts (p < 0.01). Significant neurological deficit was revealed in thrombin + tPA group in forelimb-placing and corner-turn tests (p < 0.01). This study shows that tPA potentiates the neurotoxic effects of thrombin and leads to increased BBB permeability, neuronal cell death, and neurological deficit. Our results suggest that using tPA to lyse intracerebral hematomas has potential to produce neuronal cell death and disruption of BBB.

Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia

Hydrochlorothiazide (HCTZ) is used to manage hypertension and heart failure; however, its side effects include mild hypokalemia, metabolic abnormalities, and volume depletion, which might have deleterious effects on renal and endothelial function. We studied whether HCTZ cause renal injury and/or altered vasoreactivity and if these changes are hypokalemia-dependent. Rats were given a normal diet or a diet moderately low in potassium K+ with or without HCTZ. Animals fed either a low K+ diet alone or HCTZ developed mild hypokalemia. There was no significant difference in systolic blood pressure in the different treatment groups. All three groups with hypokalemia had mild proteinuria; low K(+)-HCTZ rats had reduced creatinine clearance. HCTZ-treated rats displayed hypomagnesemia, hypertriglyceridemia, hyperglycemia, insulin resistance, and hyperaldosteronism. No renal injury was observed in the groups without HCTZ; however, increased kidney weight, glomerular ischemia, medullary injury, and cortical oxidative stress were seen with HCTZ treatment. Endothelium-dependent vasorelaxation was reduced in all hypokalemic groups and correlated with reduced serum K+, serum, and urine nitric oxide. Our results show that HCTZ is associated with greater renal injury for the same degree of hypokalemia as the low K+ diet, suggesting that factors such as chronic ischemia and hyperaldosteronism due to volume depletion may be responsible agents. We also found impaired endothelium-dependent vasorelaxation was linked to mild hypokalemia.

First-principles study: size-dependent optical properties for semiconducting silicon carbide nanotubes

Using first-principles calculations, we investigate the effect of tube size on optical properties of the zigzag, armchair, and chiral SiC nanotubes. The results indicate that the optical spectra of SiC nanotubes are dependent on the diameter and chirality, and that optical anisotropy is observed for different light polarizations. For a given chirality of SiCNTs, redshifts or blueshifts of the peaks in the dielectric function and energy loss function with increasing tube diameter are possible due to the competition between the size effect and pi orbitals overlapping, and the shifts become smaller as the tube diameter increases. The unusual optical properties of semiconducting SiC nanotubes present an opportunity for applications in electro-optical devices.

Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activity

The present study investigated the mechanisms underlying the inhibition of platelet phosphatidylserine (PS) exposure by GPIIb/IIIa blockade. Platelet PS exposure induced by thrombin stimulation was cell-cell contact dependent. GPIIb/IIIa blockade by c7E3 or SR121566 inhibited thrombin-induced platelet PS exposure. Thrombin stimulation induced mild, while A23187 induced extensive platelet-derived microparticle (PDMP) generation. Thrombin-induced PDMP generation was not inhibited by GPIIb/IIIa blockade. Aminophospholipid translocase activity was reduced upon platelet activation by thrombin. The reduction of non-PS-exposing platelets was attenuated by GPIIb/IIIa blockade, while little translocase activity was seen in PS-exposing platelets. Thrombin increased scramblase activity slightly in non-PS-exposing platelets, which was inhibited by GPIIb/IIIa blockade, and markedly enhanced scramblase activity in PS-exposing platelets. Activation of platelet calpain and caspase-3 or cytosolic calcium mobilization were not altered by GPIIb/IIIa inhibition. Thus, GPIIb/IIIa blockade inhibits platelet PS exposure by enhancing translocase activity and attenuating scramblase activity, but does not inhibit PDMP generation.

Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging Study

OBJECTIVE

To determine whether a polymorphism the in delta-aminolevulinic acid dehydratase (ALAD) gene modifies the neurotoxicity of lead in older adults.

METHODS

The authors studied men participating in the Department of Veterans Affairs' Normative Aging Study, assessing their recent exposure to lead by measuring blood lead (n = 915) at each triennial clinic visit, and, beginning in 1991, assessing their cumulative exposure by measuring lead levels in tibia (n = 722) and patella (n = 720), using K-shell x ray fluorescence. Starting in 1993 and again at each triennial visit, the authors administered the Mini-Mental State Examination (MMSE) to assess their cognitive functioning. The relation of the lead biomarkers to MMSE score was evaluated and this association was compared among men who carried the variant allele, ALAD-2, versus men without the allele.

RESULTS

Sixteen per cent of men carried the ALAD-2 allele. Median tibia and patella lead levels (first-third quartile) were 19 (13-28) and 27 (18-39) microg/g. Blood lead levels were consistent with non-occupational exposure: only 6% of men had levels > or =10 microg/dl. In multivariable adjusted analyses, higher levels of blood lead were associated with poorer performance on the MMSE. This association was most pronounced among ALAD-2 carriers, among whom a 3 microg/dl increment in blood lead (the interquartile range) was associated with a 0.26 point lower mean MMSE score (95% CI -0.54 to 0.01), compared with a 0.04 point lower score (95% CI -0.16 to 0.07) among non-carriers. The modest 0.22 point difference in these associations did not attain statistical significance, however (p(interaction) = 0.13). The associations between bone lead levels and MMSE score did not vary by ALAD-2 status.

CONCLUSIONS

Although not statistically significant, these findings suggest that ALAD genotype may modify blood lead's adverse association with cognition among older men who had community exposures to lead. However, despite a relatively large sample size and the use of sensitive methods for measuring lead burden, the evidence overall was fairly weak.

Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults

BACKGROUND

Surgical closure of patent ductus arteriosus (PDA) with severe pulmonary arterial hypertension in adults carries higher risk than in children.

OBJECTIVES

To investigate the application of self-expandable occluders for transcatheter closure of PDA associated with severe pulmonary arterial hypertension in adults, and the assessment of immediate and short-term results.

METHODS

29 adult patients (6 men, 23 women) underwent attempted transcatheter closure of PDA at a mean (standard deviation (SD)) age of 31.1 (11.4) years (range 18-58 years) and a mean (SD) weight of 54.1 (7.1) kg (range 42-71 kg). On the basis of haemodynamic and clinical data obtained before and after trial occlusion, the final duct occlusion was determined and carried out. Radiographs of the chest, electrocardiograms and echocardiograms were used for follow-up evaluation of the treatment within 1 day, 1 month and 3-6 months after successful closure.

RESULTS

20 of the 29 patients had successful occlusion (group 1), and 9 patients failed (named group 2). In group 1, in which occlusion was successful, mean (SD) pulmonary arterial pressures decreased markedly after trial occlusion: 78 (19.3) mm Hg (range 50-125 mm Hg) before occlusion and 41 (13.8) mm Hg (range 23-77 mm Hg) after occlusion. Systemic arterial oxygen saturation was found to be >90% in 19 patients and <90% in the remaining patient before inhalation of oxygen, and >95% during inhalation of oxygen or after occlusion in all 20 patients. In group 2, the occlusion was not successful, because in two patients the device was not available; another two patients showed worsening of symptoms. The other five patients showed increased pulmonary arterial pressures after trial closure; their mean (SD) pulmonary arterial pressures increased by 10.3 (6) mm Hg (4-16 mm Hg) after trial occlusion, and systemic arterial oxygen saturation was 85.5% (2.6%) (range 82.6-88%) before inhalation of oxygen and 94.7% (1.7%) (range 90.7-99.1%) during inhalation of oxygen. In group 1, the dimensions of the left atrium, left ventricle and pulmonary artery increased considerably in 3-6-months of follow-up compared with those of preocclusion.

CONCLUSIONS

Transcatheter closure is an effective treatment for adults with PDA associated with reversible severe pulmonary arterial hypertension. Further research is needed for the evaluation of long-term results.

Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release

M-current (I(M)) plays a key role in regulating neuronal excitability. Mutations in Kv7/KCNQ subunits, the molecular correlates of I(M), are associated with a familial human epilepsy syndrome. Kv7/KCNQ subunits are widely expressed, and I(M) has been recorded in somata of several types of neurons, but the subcellular distribution of M-channels remains elusive. By combining field-potential, whole-cell and intracellular recordings from area CA1 in rat hippocampal slices, and computational modelling, we provide evidence for functional M-channels in unmyelinated axons in the brain. Our data indicate that presynaptic M-channels can regulate axonal excitability and synaptic transmission, provided the axons are depolarized into the I(M) activation range (beyond approximately -65 mV). Here, such depolarization was achieved by increasing the extracellular K(+) concentration ([K(+)](o)). Extracellular recordings in the presence of moderately elevated [K(+)](o) (7-11 mm), showed that the specific M-channel blocker XE991 reduced the amplitude of the presynaptic fibre volley and the field EPSP in a [K(+)](o)-dependent manner, both in stratum radiatum and in stratum lacknosum moleculare. The M-channel opener, retigabine, had opposite effects. The higher the [K(+)](o), the greater the effects of XE991 and retigabine. Similar pharmacological modulation of EPSPs recorded intracellularly from CA1 pyramidal neurons, while blocking postsynaptic K(+) channels with intracellular Cs(+), confirmed that active M-channels are located presynaptically. Computational analysis with an axon model showed that presynaptic I(M) can control Na(+) channel inactivation and thereby affect the presynaptic action potential amplitude and Ca(2+) influx, provided the axonal membrane potential is sufficiently depolarized. Finally, we compared the effects of blocking I(M) on the spike after-depolarization and bursting in CA3 pyramidal neuron somata versus their axons. In standard [K(+)](o) (2.5 mm), XE991 increased the ADP and promoted burst firing at the soma, but not in the axons. However, I(M) contributed to the refractory period in the axons when spikes were broadened by a low dose 4-aminopyridine (200 microm). Our results indicate that functional Kv7/KCNQ/M-channels are present in unmyelinated axons in the brain, and that these channels may have contrasting effects on excitability depending on their subcellular localization.

Separate DCIS progression pathways derived from breast disease heterogeneity data

612

Background: Observation of heterogeneity in breast pathology has been a consistent theme but one that has had little detailed analysis and/or interpretation. Typically, this research has been limited due to variation in pathology description by different pathologists. We have utilized a unique breast disease tissue and data repository to infer multiple pathways from breast disease to breast cancer. Methods: Breast pathology diagnoses are drawn from 1029 standardized and highly expanded pathology reports. A single pathologist records the occurrence of any and all pathologies seen in a patient’s breast biopsy. This co-occurrence data is analyzed using a Bayesian network learning algorithm that links data observations in a probabilistic order of events. The resultant Bayesian network is a visualization of how breast disease diagnoses can predict the presence or absence of other diagnoses. For example, a connection between ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) visualizes the statement: the presence of DCIS alters the likelihood of the presence of IDC. Results: Separate progression pathways are implicated for DCIS comedo to IDC and DCIS non-comedo to IDC. Multiple breast lesions predict DCIS non-comedo occurrence. One pathway inferred from these predictive lesions is: columnar cell hyperplasia-florid ductal hyperplasia-atypical ductal hyperplasia-DCIS non-comedo-IDC. In contrast, no hyperplasia or atypical lesion can predict DCIS comedo occurrence. That DCIS comedo and DCIS non-comedo have very different progression pathways implies these two pathologies may be two separate diseases. Parallel genomic studies at our institute provide strong evidence that DCIS non-comedo and DCIS comedo are two separate genomic entities. Conclusions: Bayesian network analysis provides a mechanism for the use of heterogeneity in breast disease pathology to predict multiple breast disease progression pathways. Using novel bioinformatic techniques and traditional genomic analysis methods we have gathered compelling evidence that DCIS progression follows two separate pathways.

No significant financial relationships to disclose.

Observations of differences in laterality imbalance of breast biopsies and breast disease between Caucasian and African American women

10781

Background: A number of published reports have indicated that the left breast is at greater risk of cancer than the right breast (laterality imbalance) in women of all ages. In addition, a woman’s left breast is usually larger than her right breast. In the Clinical Breast Care Project, more than 2400 subjects have been enrolled following HIPAA compliant, IRB approved protocols. Of these, 1200 have undergone a biopsy and completed demographic and pathological questionnaires. We investigated whether there is a laterality imbalance among the patients with respect to ethnicity, menopausal status or pathological diagnoses. Methods: Female patients with biopsies on only one breast whose pathological questionnaire was completed within 90 days of the demographical questionnaire were included in this analysis but patients who were surgically post-menopausal were excluded. Multiple biopsies on one breast for each woman were counted as one event. For statistical analysis, Pearson’s chi-square test in SPSS was used. Results: Of the 1200 patients, 708 (546 caucasian; CA and 172 African American; AA) satisfied the above criteria. Although the total number of biopsy events are essentially evenly distributed on either breast for either ethnicity, statistical analysis showed that post menopausal CA women have fewer biopsy events on the left breast (41%, n=264) than their pre-menopausal counterparts (52%, n = 282; p < 0.05); On the contrary, post-menopausal AA women have significantly more biopsy events on the left breast (62%, n=50) than their pre-menopausal counterparts (42%, n = 122; p = 0.02). Further analysis based on pathological diagnoses indicated that benign, pre-menopausal, AA patients have fewer events on the left breast (42%, n = 98) compared to CA (54%, n = 211; p < 0.05). Discussions: Despite the small sample size, the data nonetheless suggest that there are significant, menopausal status dependent, laterality imbalances of breast disease biopsy among CA and AA women. These differences await evaluation.

No significant financial relationships to disclose.